- May 2018 Cancer researchers at the MD Anderson Cancer Center use Redoxica's 2-Cys-Peroxiredoxin Activity Assay technology to determine that SIRT2 deacetylates and inhibits the peroxidase activity of peroxiredoxin-1 to sensitize breast cancer cells to oxidant stress-inducing agents.
- April 2018 Redoxica Partners with Leading Lab Ordering Platform for Fulfillment
- March 2018 Researchers at Yale University School of Medicine utilized Redoxica's Thioredoxin Activity Assay technology to measure the Trx2 activity in cardiac mitochondria from human and mouse heart tissue.
- February 2018 A team of researchers at University of Pittsburgh's School of Medicine use Redoxica's 2-Cys-Peroxiredoxin Activity Assay Kit and the Thioredoxin Activity Assay Kit to determine Prx and Trx activity.